Immatics NV (IMTX) Stock Price, Quote, News & History

IMTXNASDAQ
$9.23
-0.45-4.65%
At close: Jul 13, 5:00 PM EST
$9.23
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-184.46M
Investing Cash Flow (TTM)
129.90M
Financing Cash Flow (TTM)
119.06M
Free Cash Flow (TTM)
-188.90M
Capital Expenditure (TTM)
-4.43M
Net Change in Cash (TTM)
64.49M

Analyst Trends and Forecast

1
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$823.64M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
28.63
PB Ratio (TTM)
2.55
Earnings Yield % (TTM)
-20.12%
Earnings Yield % (FWD)
-23.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.80

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$301.33M
Debt to Equity
0.03
Issuance of Debt (TTM)
-$2.98M
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.53
Close
$9.23
Volume / Avg.
178.91K / 469.77K
Day Range
$9.20 - $9.70
52 Wk Range
5.05 - 12.41
Market Cap
$1.24B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
4.86%
Days to Cover
13.3

About

Sector
Health Care
Industry
Biotechnology
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Immatics (IMTX) stock?

A

You can purchase shares of Immatics (NASDAQ:IMTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immatics (IMTX) competitors?

A

There are no as such competitors for Immatics.

Q

What is the forecast, or price target, for Immatics (IMTX) stock?

A

Immatics has a consensus price target of $18.43.

Q

What is the current price for Immatics (IMTX)?

A

The stock price for Immatics (NASDAQ: IMTX) is $9.23 last updated July 13, 2026 at 4:00 PM EDT.

Q

Does Immatics (IMTX) pay a dividend?

A

There are no upcoming dividends for Immatics.

Q

When is Immatics (NASDAQ:IMTX) reporting earnings?

A

Immatics does not have any upcoming earnings scheduled.

Q

Is Immatics (IMTX) going to split?

A

There is no upcoming split for Immatics.

Q

What sector and industry does Immatics (IMTX) operate in?

A

Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.